# OnCo record childhood-cancers (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/childhood-cancers/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "childhood-cancers" ;
  schema:name "Childhood cancers (all types)"@en ;
  schema:alternateName "Childhood Cancers"@en, "Paediatric cancers"@en, "Pediatric cancers"@en, "Cancer in children"@en, "Young Adults, Cancer in"@en, "Adolescent and young adult cancer"@en ;
  schema:description "Cancer in children is rare and different from adult cancer: the common types are leukaemias, brain tumours, lymphomas and embryonal tumours such as neuroblastoma and Wilms tumour, most are curable in well-resourced health systems, and the great challenge is bringing the same cures to the majority of children who live where they are not available."@en ;
  schema:url <https://onco.cc/cancers/childhood-cancers/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Childhood_cancer> ;
  schema:citation <https://www.cancer.gov/types/childhood-cancers>, <https://www.who.int/initiatives/the-global-initiative-for-childhood-cancer> ;
  onco:tag "paediatric", "umbrella" ;
  onco:related <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/medulloblastoma/>, <https://onco.cc/cancers/dipg-dmg/>, <https://onco.cc/cancers/ependymoma/>, <https://onco.cc/cancers/paediatric-low-grade-glioma/>, <https://onco.cc/cancers/atrt/>, <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/retinoblastoma/>, <https://onco.cc/cancers/hepatoblastoma/>, <https://onco.cc/cancers/rhabdomyosarcoma/>, <https://onco.cc/cancers/osteosarcoma/>, <https://onco.cc/cancers/ewing-sarcoma/>, <https://onco.cc/cancers/paediatric-germ-cell-tumours/>, <https://onco.cc/cancers/pleuropulmonary-blastoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/burkitt-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/gd2/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/dinutuximab/> ;
  onco:trials <https://onco.cc/trials/nct05491525/>, <https://onco.cc/trials/nct04851717/>, <https://onco.cc/trials/nct05948943/>, <https://onco.cc/trials/nct06055959/>, <https://onco.cc/trials/nct06149559/> ;
  onco:pipeline <https://onco.cc/drugs/naxitamab/>, <https://onco.cc/drugs/tovorafenib/>, <https://onco.cc/drugs/obecabtagene-autoleucel/> ;
  onco:standardOfCare <https://onco.cc/drugs/blinatumomab/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/dinutuximab/>, <https://onco.cc/technologies/survivorship-care-plan/> .